Drreddys Laboratories | RDY - Ebitda





Ebitda Cambiamento Data
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
Aurora Cannabis CAD 15.37M 26.8M 2025-09
Bayer EUR 1.97B 457M 2025-12
Canopy Growth CAD 16.62M 38.45M 2025-09
Cipla INR 12.55B 6.4B 2025-12
Corcept Therapeutics USD 4.2M 6.5M 2025-12
Drreddys Laboratories INR 21.59B 1.49B 2025-12
GlaxoSmithKline GBP 3.36B 179M 2025-09
Hikma Pharmaceutical USD 369M 84M 2024-12
Lonza CHF 1.01B 54M 2025-12
Novartis USD 5.88B 290M 2025-09
Pacira USD 38.71M 10.65M 2025-12
Phibro Animal Health USD 30.48M 1.1M 2024-09
Prestige Brands USD 90.82M 3.99M 2025-12
Richter Gedeon HUF 75.72B 6.71B 2024-09
Sun Pharmaceuticals INR 49.48B 8.52B 2025-12
Supernus Pharmaceuticals USD 48.5M 6.6M 2025-12
Teva Pharmaceutical Industries USD 1.64B 243M 2025-12